XML 28 R17.htm IDEA: XBRL DOCUMENT
v3.20.4

GOODWILL AND OTHER INTANGIBLE ASSETS (Notes) | 3 Months Ended
--- | ---
Jan. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract] |
GOODWILL AND OTHER INTANGIBLE ASSETS | GOODWILL AND OTHER INTANGIBLE ASSETS The following table presents goodwill balances and the movements for each of our reportable segments during the three months ended January 31, 2021:
| Life Sciences and Applied Markets |  | Diagnostics and Genomics |  | Agilent CrossLab |  | Total
| (in millions)
Goodwill as of October 31, 2020 | $ | 1,441 |  |  | $ | 1,599 |  |  | $ | 562 |  |  | $ | 3,602 |
Foreign currency translation impact | 8 |  |  | 3 |  |  | 5 |  |  | 16 |
Goodwill as of January 31, 2021 | $ | 1,449 |  |  | $ | 1,602 |  |  | $ | 567 |  |  | $ | 3,618 |
The component parts of other intangible assets as of January 31, 2021 and October 31, 2020 are shown in the table below:
| Other Intangible Assets
| Gross Carrying Amount |  | Accumulated Amortization |  | Net Book Value
| (in millions)
As of October 31, 2020 |  |  |  |  |
Purchased technology | $ | 1,429 |  |  | $ | 863 |  |  | $ | 566 |
Trademark/Tradename | 196 |  |  | 117 |  |  | 79 |
Customer relationships | 330 |  |  | 158 |  |  | 172 |
Third-party technology and licenses | 11 |  |  | 7 |  |  | 4 |
Total amortizable intangible assets | 1,966 |  |  | 1,145 |  |  | 821 |
In-Process R&D | 10 |  |  | — |  |  | 10 |
Total | $ | 1,976 |  |  | $ | 1,145 |  |  | $ | 831 |
As of January 31, 2021 |  |  |  |  |
Purchased technology | $ | 1,433 |  |  | $ | 891 |  |  | $ | 542 |
Trademark/Tradename | 196 |  |  | 121 |  |  | 75 |
Customer relationships | 332 |  |  | 176 |  |  | 156 |
Third-party technology and licenses | 10 |  |  | 7 |  |  | 3 |
Total amortizable intangible assets | 1,971 |  |  | 1,195 |  |  | 776 |
In-Process R&D | 11 |  |  | — |  |  | 11 |
Total | $ | 1,982 |  |  | $ | 1,195 |  |  | $ | 787 |
During the three months ended January 31, 2021, there were no additions to goodwill or to other intangible assets. During the three months ended January 31, 2021, other intangible assets in total increased $1 million due to the impact of foreign currency translation. In general, for United States federal tax purposes, goodwill from asset purchases is deductible; however, any goodwill created as part of a stock acquisition is not deductible. Each quarter we review the events and circumstances to determine if impairment of indefinite-lived intangible assets and goodwill is indicated. During the three months ended January 31, 2021 and 2020 we did not identify any triggering events or circumstances, including impacts due to COVID-19, which would indicate an impairment of goodwill or indefinite-lived intangible assets. Amortization expense of intangible assets was $45 million and $48 million for the three months ended January 31, 2021 and 2020, respectively. Future amortization expense related to existing finite-lived purchased intangible assets for the remainder of fiscal year 2021 and for each of the next five fiscal years and thereafter is estimated below:
Estimated future amortization expense: |
(in millions) |
Remainder of 2021 | $ | 129 |
2022 | $ | 152 |
2023 | $ | 109 |
2024 | $ | 88 |
2025 | $ | 70 |
2026 | $ | 40 |
Thereafter | $ | 188 |

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI http://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration